SCHEMBL20122848

SCHEMBL20122848

CCn1c2cnccc2c2cc(Cl)cc(Br)c21

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 7/20 0.42
KDM5A P29375 1/20 0.41
HASPIN Q8TF76 1/20 0.35
METAP2 P50579 2/20 0.35
DYRK1A Q13627 1/20 0.34
CHUK O15111 2/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 1/20 0.33
S1PR1 P21453 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122701 0.85 ROCK2 (0.33) ROCK2KDM5AHASPINDYRK1ACHUK
SCHEMBL20122869 0.84 NFATC1 (0.42) ROCK2HASPINDYRK1ASLC6A2SLC6A4
SCHEMBL20122856 0.83 ROCK2 (0.43) ROCK2METAP2CHUK
SCHEMBL20122698 0.82 ROCK2 (0.44) ROCK2METAP2DYRK1ACHUKSLC6A2
SCHEMBL20122892 0.82 METAP2 (0.44) ROCK2KDM5AMETAP2DYRK1ACYP1A2
SCHEMBL30664293 0.82 METAP2 (0.44) ROCK2KDM5AMETAP2DYRK1ACYP1A2
SCHEMBL20123010 0.81 ROCK2 (0.40) ROCK2KDM5AMETAP2DYRK1AS1PR1
SCHEMBL30664221 0.81 ROCK2 (0.40) ROCK2KDM5AMETAP2DYRK1AS1PR1
SCHEMBL20122707 0.80 DYRK1A (0.46) ROCK2HASPINDYRK1ACHUK
SCHEMBL30664233 0.80 ROCK2 (0.39) ROCK2KDM5AHASPINMETAP2DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2023-11-28 US disclosed
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2023-11-28 US disclosed
CN-110382496-B Substituted pyrido [3,4-b ] indoles for the treatment of cartilage disorders 赛诺菲 2022-08-09 CN disclosed
US-11130755-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders SANOFI (FR) 2021-09-28 US disclosed
EP-3792262-A1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI (FR) 2021-03-17 EP disclosed
EP-3535263-B1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI SA (FR) 2020-09-30 EP disclosed
EP-3318563-A1 SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS SANOFI (FR) 2018-05-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11827633-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders COL2A1, IDO1, COL1A1 ROCK2 1093/4885KDM5A 888/4885HASPIN 2412/4885
US-11130755-B2 Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders COL2A1, IDO1, COL1A1 ROCK2 1093/4885KDM5A 888/4885HASPIN 2412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.